PIHN Hires New Medical Director to Start International Clinical Trials
01 Abril 2014 - 4:45AM
Marketwired
PIHN Hires New Medical Director to Start International Clinical
Trials
PLANO, TX--(Marketwired - Apr 1, 2014) - Polaris International
Holdings, Inc. (OTC Pink: PIHN) (PINKSHEETS: PIHN) is pleased to
announce the Company has added Dr. Vasthi Alvarez Avila as Medical
Director and to the Corporate Board of Directors. Dr. Alvarez
Avila graduated from Universidad De Montemorelos in
Mexico. She has 8 years of medical service in Family Practice
and General Surgery throughout Mexico.
Dr. Alvarez Avila will be overseeing product trials preformed by
the Company in the United States and as it makes further progress
toward initiating trials in Mexico and India. Dr. Alverez said, "We
want to establish our international brand and reputation for
excellence, demonstrating through our professionally managed trials
that our products represent the highest quality, most consistent
dosage delivery results and prove to our participating physician
base that we have a pharmaceutical grade solution that they can
rely on." Polaris International Holdings is also currently in
the process of procuring additional specialized Doctors
internationally to conduct the trials.
Previous reports from The National Cancer Institute showing that
the programmed death of breast cancer cell in presence of CBD and
the possibility that CBD may also enhance uptake of cytotoxic drugs
into certain malignant cells is very promising. A refined CBD
completely void of THC a myriad of uses in a number of specialties
including pain management, sports medicine, preventative medicine
and oncology, possibly increasing the effectiveness of some
chemotherapy.
"The healing powers of cannabinoids have only been touched upon
in research. Without the THC psychotropic effects of medical
marijuana, the general acceptance of the therapeutic qualities of
marijuana will be more highly embraced by the general population
and the risks of administering the CBD without THC to the elderly,
and those with compromised health may be greatly decreased," states
Dr. Alvarez Avila.
Safe Harbor Statement:
This news release includes
forward-looking statements pertaining to future anticipated
projected plans, performance and developments, intended to qualify
for the safe harbor from liability established by the Private
Securities Litigation Reform Act of 1995. Any statements on this
news release that are not statements of historical fact should be
considered forward-looking statements. These forward-looking
statements generally can be identified by phrases such as
"believes," "expects," "anticipates," "foresees," "forecasts,"
"estimates," "intends," or other words or phrases of similar
import. Similarly, statements in this news release that describe
the Company's business strategy, outlook, objectives, plans,
intentions or goals also are forward-looking statements. All such
forward-looking statements are subject to certain risks and
uncertainties that could cause actual results to differ materially
from those in forward-looking statements.
Investor Inquiries: Polaris International Holdings, Inc.
Info@polaris-int.com
Polaris (CE) (USOTC:PIHN)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Polaris (CE) (USOTC:PIHN)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024